234768-83-3

Basic information

• Product Name: Hexanoic acid, 2-[[(phenylmethoxy)amino]methyl]-, (2R)-
• CAS NO: 234768-83-3
• Molecular Formula: C14H21NO3
• Molecular Weight: 251.326
• Mol File: 234768-83-3.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Hexanoic acid, 2-[[(phenylmethoxy)amino]methyl]-, (2R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Hexanoic acid, 2-[[(phenylmethoxy)amino]methyl]-, (2R)-(234768-83-3)
• EPA Substance Registry System: Hexanoic acid, 2-[[(phenylmethoxy)amino]methyl]-, (2R)-(234768-83-3)

Safety Data

• Hazardous Substances Data: 234768-83-3(Hazardous Substances Data)

Upstream product

• 234768-82-2 4S-benzyl-3-[2R-(benzyloxyamino-methyl)-hexanoyl]-5,5-dimethyl-oxazolidin-2-one, p-toluenesulfonic acid salt of 
• 478912-43-5 4-benzyl-3-[2-(benzyloxyamino-methyl)-hexanoyl]-oxazolidin-2-one 
• 676127-81-4 (2R)-2-(hydroxymethyl)-N-[(phenylmethyl)oxy]hexanamide 
• 676127-83-6 C₁₅H₂₃NO₅S 
• 676127-84-7 (3R)-3-butyl-1-[(phenylmethyl)oxy]-2-azetidinone 
• 2612-26-2 2-butylpropane-1,3-diol 
• 58243-89-3 (±)-2-butyl-3-hydroxypropionic acid 
• 2985-32-2 butylmalonic acid monoethyl ester 
• 142-61-0 Hexanoyl chloride 
• 668485-39-0 (4S)-3-[(2R)-2-(hydroxymethyl)hexanoyl]-4-(phenylmethyl)-1,3-oxazolidin-2-one 
• 29601-98-7 N-benzylhydroxylamine hydrochloride 
• 143965-32-6 (4S)-3-hexanoyl-4-(phenylmethyl)-1,3-oxazolidin-2-one 

Downstream Products

• 1281973-31-6 C₂₀H₂₉N₃O₅ 
• 1101196-58-0 C₁₉H₂₇N₃O₅ 
• 1101196-52-4 C₂₀H₂₉N₃O₅ 
• 1101196-53-5 C₁₉H₂₆FN₃O₅ 
• 1101196-54-6 C₂₃H₃₃FN₄O₆ 
• 1101196-55-7 C₂₃H₃₃ClN₄O₆ 
• 1281973-26-9 C₂₅H₃₁N₃O₅ 
• 1101196-43-3 C₁₈H₂₅N₃O₅ 
• 1101196-81-9 C₂₆H₃₃N₃O₅ 
• 1101196-83-1 C₂₅H₃₀FN₃O₅ 
• 1281973-27-0 C₂₅H₂₉F₂N₃O₅ 
• 1101196-85-3 C₂₆H₃₃N₃O₆ 
• 1101196-87-5 C₂₉H₃₇FN₄O₆ 
• 1101196-88-6 C₂₉H₃₇ClN₄O₆ 

Relevant articles and documents

Peptide deformylase inhibitors

The present invention relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods directed to bacterial infections and inhibition of bacterial peptide deformylase (PDF) activity.

Synthesis and in vitro antibacterial activity of oxazolidine LBM-415 analogs as peptide deformylase inhibitors

The drug resistant bacteria pose a severe threat to human health. The increasing resistance of those pathogens to traditional antibacterial therapy renders the identification of new antibacterial agents with novel antibacterial mechanisms an urgent need.

A practical enantioselective synthesis of a novel peptide deformylase inhibitor

A practical synthesis of the peptide deformylase inhibitor LBM415,(2S)-N-(5-fluoro-1-oxido-2-pyridinyl)-1-[(2R)-2-[(formylhydroxyamino) methyl]-1-oxohexyl]-2-pyrrolidinecarboxamide, magnesium salt 11, is described. The key chiral intermediate, (2S)-N-(5-f